English

ChemoMetec A/S e

ESEF

Report (type unavailable) · filed 2026-10-15

Annual consolidated revenue for 2026: about DKK 511.1M, using the latest reported figures. The previous period, 2025, was about DKK 495.6M.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

511 million DKK

2026 · DKK

Exact inputs and evidence

Revenue: 511057000 DKK Source

Operating margin

49.11%

2026 · %

Exact inputs and evidence

Operating Income: 250995000 DKK Source
Revenue: 511057000 DKK Source

Operating cash flow

210 million DKK

2026 · DKK

Exact inputs and evidence

Operating Cash Flow: 210356000 DKK Source

Free cash flow

182 million DKK

2026 · DKK

Exact inputs and evidence

Operating Cash Flow: 210356000 DKK Source
Capital Expenditure: 28311000 DKK Source

Cash and cash equivalents: 290 million DKK 2026-06-30 Source
Exact value

290170000 DKK
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-15.

Financial data available through: 2026-06-30.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2026-06-30
Operating income: 6 of 11 periods available· newest 2026-06-30
net income: No compatible figures in this window
Operating cash flow: 6 of 11 periods available· newest 2026-06-30
Capital expenditure: 6 of 11 periods available· newest 2026-06-30
Total assets: 6 of 11 periods available· newest 2026-06-30
Total liabilities: 6 of 11 periods available· newest 2026-06-30
Current assets: 6 of 11 periods available· newest 2026-06-30
Current liabilities: 6 of 11 periods available· newest 2026-06-30
Cash and cash equivalents: 6 of 11 periods available· newest 2026-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.1%

Prior period

DKK 495.57 million

2024-07-01 – 2025-06-30
Current period

DKK 511.06 million

2025-07-01 – 2026-06-30

Exact inputs and evidence

511057000 − 495572000 = 15485000 DKK

495572000 DKK · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
511057000 DKK · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Year-over-year change in Revenue: 15485000 DKK Concept: fundies:Revenue Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 511057000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21152623 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 Input fundies:Revenue: 495572000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21153633 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+1.4%

Prior period

DKK 207.45 million

2024-07-01 – 2025-06-30
Current period

DKK 210.36 million

2025-07-01 – 2026-06-30

Exact inputs and evidence

210356000 − 207449000 = 2907000 DKK

207449000 DKK · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
210356000 DKK · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Year-over-year change in Operating cash flow: 2907000 DKK Concept: fundies:OperatingCashFlow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 210356000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21280958 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 Input fundies:OperatingCashFlow: 207449000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21282084 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-5.2%

Prior period

DKK 29.87 million

2024-07-01 – 2025-06-30
Current period

DKK 28.31 million

2025-07-01 – 2026-06-30

Exact inputs and evidence

28311000 − 29867000 = -1556000 DKK

29867000 DKK · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
28311000 DKK · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Year-over-year change in Capital expenditure: -1556000 DKK Concept: fundies:CapitalExpenditure Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 28311000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21284777 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 29867000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21285962 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-07-01 – 2026-06-30

Revenue DKK 511.06 million 100% of revenue
Operating costs Derived DKK 260.06 million 51% of revenue
Operating income DKK 251 million 49% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow DKK 210.36 million 41% of revenue
Capital expenditure DKK 28.31 million 5.5% of revenue
Free cash flow Derived DKK 182.05 million 36% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.
2025 Not shown: operating income or net income is not reported.
2026 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2021 2020-07-01 – 2021-06-30	281127000	165104000 Derived	116023000	Unavailable	Unavailable	96652000 Derived	Source 2020-07-01 – 2021-06-30: 281127000 DKK Inspect Revenue Open source 2020-07-01 – 2021-06-30: 116023000 DKK Inspect Operating Income Open source 2020-07-01 – 2021-06-30: 107901000 DKK Inspect Operating Cash Flow Open source 2020-07-01 – 2021-06-30: 11249000 DKK Inspect Capital Expenditure Open source
2022 2021-07-01 – 2022-06-30	427160000	224306000 Derived	202854000	Unavailable	Unavailable	137759000 Derived	Source 2021-07-01 – 2022-06-30: 427160000 DKK Inspect Revenue Open source 2021-07-01 – 2022-06-30: 202854000 DKK Inspect Operating Income Open source 2021-07-01 – 2022-06-30: 176860000 DKK Inspect Operating Cash Flow Open source 2021-07-01 – 2022-06-30: 39101000 DKK Inspect Capital Expenditure Open source
2023 2022-07-01 – 2023-06-30	442274000	211713000 Derived	230561000	Unavailable	Unavailable	132965000 Derived	Source 2022-07-01 – 2023-06-30: 442274000 DKK Inspect Revenue Open source 2022-07-01 – 2023-06-30: 230561000 DKK Inspect Operating Income Open source 2022-07-01 – 2023-06-30: 154146000 DKK Inspect Operating Cash Flow Open source 2022-07-01 – 2023-06-30: 21181000 DKK Inspect Capital Expenditure Open source
2024 2023-07-01 – 2024-06-30	407350000	238384000 Derived	168966000	Unavailable	Unavailable	108055000 Derived	Source 2023-07-01 – 2024-06-30: 407350000 DKK Inspect Revenue Open source 2023-07-01 – 2024-06-30: 168966000 DKK Inspect Operating Income Open source 2023-07-01 – 2024-06-30: 129002000 DKK Inspect Operating Cash Flow Open source 2023-07-01 – 2024-06-30: 20947000 DKK Inspect Capital Expenditure Open source
2025 2024-07-01 – 2025-06-30	495572000	259056000 Derived	236516000	Unavailable	Unavailable	177582000 Derived	Source 2024-07-01 – 2025-06-30: 495572000 DKK Inspect Revenue Open source 2024-07-01 – 2025-06-30: 236516000 DKK Inspect Operating Income Open source 2024-07-01 – 2025-06-30: 207449000 DKK Inspect Operating Cash Flow Open source 2024-07-01 – 2025-06-30: 29867000 DKK Inspect Capital Expenditure Open source
2026 2025-07-01 – 2026-06-30	511057000	260062000 Derived	250995000	Unavailable	Unavailable	182045000 Derived	Source 2025-07-01 – 2026-06-30: 511057000 DKK Inspect Revenue Open source 2025-07-01 – 2026-06-30: 250995000 DKK Inspect Operating Income Open source 2025-07-01 – 2026-06-30: 210356000 DKK Inspect Operating Cash Flow Open source 2025-07-01 – 2026-06-30: 28311000 DKK Inspect Capital Expenditure Open source

Amounts are exact, in DKK.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

DKK 511.1M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(DKK)	Source evidence
20212021-06-30	Revenue	281127000	Revenue: 281127000 Open source
20222022-06-30	Revenue	427160000	Revenue: 427160000 Open source
20232023-06-30	Revenue	442274000	Revenue: 442274000 Open source
20242024-06-30	Revenue	407350000	Revenue: 407350000 Open source
20252025-06-30	Revenue	495572000	Revenue: 495572000 Open source
20262026-06-30	Revenue	511057000	Revenue: 511057000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.1% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20212021-06-30	Year over year	No prior comparable period	Revenue: 281127000 Open source
20222022-06-30	Year over year	51.9%	Revenue: 427160000 Open source Revenue: 281127000 Open source
20232023-06-30	Year over year	3.5%	Revenue: 442274000 Open source Revenue: 427160000 Open source
20242024-06-30	Year over year	-7.9%	Revenue: 407350000 Open source Revenue: 442274000 Open source
20252025-06-30	Year over year	21.7%	Revenue: 495572000 Open source Revenue: 407350000 Open source
20262026-06-30	Year over year	3.1%	Revenue: 511057000 Open source Revenue: 495572000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 49.1% 2026

Free cash flow margin 35.6% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20212021-06-30	Operating margin	41.3%	Operating Income: 116023000 Open source Revenue: 281127000 Open source
20222022-06-30	Operating margin	47.5%	Operating Income: 202854000 Open source Revenue: 427160000 Open source
20232023-06-30	Operating margin	52.1%	Operating Income: 230561000 Open source Revenue: 442274000 Open source
20242024-06-30	Operating margin	41.5%	Operating Income: 168966000 Open source Revenue: 407350000 Open source
20252025-06-30	Operating margin	47.7%	Operating Income: 236516000 Open source Revenue: 495572000 Open source
20262026-06-30	Operating margin	49.1%	Operating Income: 250995000 Open source Revenue: 511057000 Open source
2021-06-30	Net margin	Not reported	Revenue: 281127000 Open source
2022-06-30	Net margin	Not reported	Revenue: 427160000 Open source
2023-06-30	Net margin	Not reported	Revenue: 442274000 Open source
2024-06-30	Net margin	Not reported	Revenue: 407350000 Open source
2025-06-30	Net margin	Not reported	Revenue: 495572000 Open source
2026-06-30	Net margin	Not reported	Revenue: 511057000 Open source
20212021-06-30	Free cash flow margin	34.4%	Revenue: 281127000 Open source Operating Cash Flow: 107901000 Open source Capital Expenditure: 11249000 Open source
20222022-06-30	Free cash flow margin	32.2%	Revenue: 427160000 Open source Operating Cash Flow: 176860000 Open source Capital Expenditure: 39101000 Open source
20232023-06-30	Free cash flow margin	30.1%	Revenue: 442274000 Open source Operating Cash Flow: 154146000 Open source Capital Expenditure: 21181000 Open source
20242024-06-30	Free cash flow margin	26.5%	Revenue: 407350000 Open source Operating Cash Flow: 129002000 Open source Capital Expenditure: 20947000 Open source
20252025-06-30	Free cash flow margin	35.8%	Revenue: 495572000 Open source Operating Cash Flow: 207449000 Open source Capital Expenditure: 29867000 Open source
20262026-06-30	Free cash flow margin	35.6%	Revenue: 511057000 Open source Operating Cash Flow: 210356000 Open source Capital Expenditure: 28311000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

DKK 210.4M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(DKK)	Source evidence
20212021-06-30	Operating cash flow	107901000	Operating Cash Flow: 107901000 Open source
20222022-06-30	Operating cash flow	176860000	Operating Cash Flow: 176860000 Open source
20232023-06-30	Operating cash flow	154146000	Operating Cash Flow: 154146000 Open source
20242024-06-30	Operating cash flow	129002000	Operating Cash Flow: 129002000 Open source
20252025-06-30	Operating cash flow	207449000	Operating Cash Flow: 207449000 Open source
20262026-06-30	Operating cash flow	210356000	Operating Cash Flow: 210356000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

DKK 182M 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(DKK)	Source evidence
20212021-06-30	Free cash flow	96652000	Operating Cash Flow: 107901000 Open source Capital Expenditure: 11249000 Open source
20222022-06-30	Free cash flow	137759000	Operating Cash Flow: 176860000 Open source Capital Expenditure: 39101000 Open source
20232023-06-30	Free cash flow	132965000	Operating Cash Flow: 154146000 Open source Capital Expenditure: 21181000 Open source
20242024-06-30	Free cash flow	108055000	Operating Cash Flow: 129002000 Open source Capital Expenditure: 20947000 Open source
20252025-06-30	Free cash flow	177582000	Operating Cash Flow: 207449000 Open source Capital Expenditure: 29867000 Open source
20262026-06-30	Free cash flow	182045000	Operating Cash Flow: 210356000 Open source Capital Expenditure: 28311000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

15.7% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20212021-06-30	Liabilities / assets	23.2%	Total Liabilities: 79932000 Open source Total Assets: 344909000 Open source
20222022-06-30	Liabilities / assets	28.7%	Total Liabilities: 144068000 Open source Total Assets: 501273000 Open source
20232023-06-30	Liabilities / assets	19%	Total Liabilities: 124934000 Open source Total Assets: 657976000 Open source
20242024-06-30	Liabilities / assets	16.5%	Total Liabilities: 111357000 Open source Total Assets: 676673000 Open source
20252025-06-30	Liabilities / assets	18%	Total Liabilities: 151409000 Open source Total Assets: 839461000 Open source
20262026-06-30	Liabilities / assets	15.7%	Total Liabilities: 135505000 Open source Total Assets: 860899000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.09× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20212021-06-30	Current assets / current liabilities	3.4×	Current Assets: 244357000 Open source Current Liabilities: 71973000 Open source
20222022-06-30	Current assets / current liabilities	2.57×	Current Assets: 352934000 Open source Current Liabilities: 137378000 Open source
20232023-06-30	Current assets / current liabilities	4.13×	Current Assets: 492661000 Open source Current Liabilities: 119191000 Open source
20242024-06-30	Current assets / current liabilities	4.97×	Current Assets: 489796000 Open source Current Liabilities: 98529000 Open source
20252025-06-30	Current assets / current liabilities	3.86×	Current Assets: 554577000 Open source Current Liabilities: 143711000 Open source
20262026-06-30	Current assets / current liabilities	4.09×	Current Assets: 524801000 Open source Current Liabilities: 128246000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2021 2020-07-01 – 2021-06-30	Unavailable Not reported for this period.	DKK 107.9 million Exact value Exact value: 107901000 DKK 2020-07-01 – 2021-06-30: 107901000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2021-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 107901000 DKK Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 107901000 DKK (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2022-06-30/ESEF/DK/0/chemometec-2022-06-30-da.zip#51820480 Filing: 213800533NBKECGONO68-2022-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 11.25 million Exact value Exact value: 11249000 DKK 2020-07-01 – 2021-06-30: 11249000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2021-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 11249000 DKK Concept: fundies:CapitalExpenditure Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 11249000 DKK (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2022-06-30/ESEF/DK/0/chemometec-2022-06-30-da.zip#51826749 Filing: 213800533NBKECGONO68-2022-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 96.65 million Calculation and evidence 107901000 − 11249000 DKK Exact free cash flow: 96652000 DKK 2020-07-01 – 2021-06-30: 107901000 DKK · Inspect Operating Cash Flow · Source 2020-07-01 – 2021-06-30: 11249000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2021-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 96652000 DKK Concept: free-cash-flow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 107901000 DKK (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2022-06-30/ESEF/DK/0/chemometec-2022-06-30-da.zip#51820480 Filing: 213800533NBKECGONO68-2022-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 11249000 DKK (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2022-06-30/ESEF/DK/0/chemometec-2022-06-30-da.zip#51826749 Filing: 213800533NBKECGONO68-2022-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.
2022 2021-07-01 – 2022-06-30	Unavailable Not reported for this period.	DKK 176.86 million Exact value Exact value: 176860000 DKK 2021-07-01 – 2022-06-30: 176860000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2022-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 176860000 DKK Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 176860000 DKK (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2023-06-30/ESEF/DK/0/chemometec-2023-06-30-da.zip#39676248 Filing: 213800533NBKECGONO68-2023-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 39.1 million Exact value Exact value: 39101000 DKK 2021-07-01 – 2022-06-30: 39101000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2022-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 39101000 DKK Concept: fundies:CapitalExpenditure Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 39101000 DKK (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2023-06-30/ESEF/DK/0/chemometec-2023-06-30-da.zip#39683973 Filing: 213800533NBKECGONO68-2023-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 137.76 million Calculation and evidence 176860000 − 39101000 DKK Exact free cash flow: 137759000 DKK 2021-07-01 – 2022-06-30: 176860000 DKK · Inspect Operating Cash Flow · Source 2021-07-01 – 2022-06-30: 39101000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2022-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 137759000 DKK Concept: free-cash-flow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 176860000 DKK (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2023-06-30/ESEF/DK/0/chemometec-2023-06-30-da.zip#39676248 Filing: 213800533NBKECGONO68-2023-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 39101000 DKK (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2023-06-30/ESEF/DK/0/chemometec-2023-06-30-da.zip#39683973 Filing: 213800533NBKECGONO68-2023-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.
2023 2022-07-01 – 2023-06-30	Unavailable Not reported for this period.	DKK 154.15 million Exact value Exact value: 154146000 DKK 2022-07-01 – 2023-06-30: 154146000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2023-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 154146000 DKK Concept: fundies:OperatingCashFlow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 154146000 DKK (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2024-06-30/ESEF/DK/0/213800533NBKECGONO68-2024-06-30.zip#40094795 Filing: 213800533NBKECGONO68-2024-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 21.18 million Exact value Exact value: 21181000 DKK 2022-07-01 – 2023-06-30: 21181000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2023-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 21181000 DKK Concept: fundies:CapitalExpenditure Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 21181000 DKK (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2024-06-30/ESEF/DK/0/213800533NBKECGONO68-2024-06-30.zip#40101364 Filing: 213800533NBKECGONO68-2024-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 132.97 million Calculation and evidence 154146000 − 21181000 DKK Exact free cash flow: 132965000 DKK 2022-07-01 – 2023-06-30: 154146000 DKK · Inspect Operating Cash Flow · Source 2022-07-01 – 2023-06-30: 21181000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2023-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 132965000 DKK Concept: free-cash-flow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 154146000 DKK (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2024-06-30/ESEF/DK/0/213800533NBKECGONO68-2024-06-30.zip#40094795 Filing: 213800533NBKECGONO68-2024-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 21181000 DKK (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2024-06-30/ESEF/DK/0/213800533NBKECGONO68-2024-06-30.zip#40101364 Filing: 213800533NBKECGONO68-2024-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.
2024 2023-07-01 – 2024-06-30	Unavailable Not reported for this period.	DKK 129 million Exact value Exact value: 129002000 DKK 2023-07-01 – 2024-06-30: 129002000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2024-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 129002000 DKK Concept: fundies:OperatingCashFlow Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 129002000 DKK (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2025-06-30/ESEF/DK/0/213800533NBKECGONO68-2025-06-30.zip#59641029 Filing: 213800533NBKECGONO68-2025-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 20.95 million Exact value Exact value: 20947000 DKK 2023-07-01 – 2024-06-30: 20947000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2024-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 20947000 DKK Concept: fundies:CapitalExpenditure Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 20947000 DKK (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2025-06-30/ESEF/DK/0/213800533NBKECGONO68-2025-06-30.zip#59646887 Filing: 213800533NBKECGONO68-2025-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 108.06 million Calculation and evidence 129002000 − 20947000 DKK Exact free cash flow: 108055000 DKK 2023-07-01 – 2024-06-30: 129002000 DKK · Inspect Operating Cash Flow · Source 2023-07-01 – 2024-06-30: 20947000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2024-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 108055000 DKK Concept: free-cash-flow Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 129002000 DKK (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2025-06-30/ESEF/DK/0/213800533NBKECGONO68-2025-06-30.zip#59641029 Filing: 213800533NBKECGONO68-2025-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 20947000 DKK (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2025-06-30/ESEF/DK/0/213800533NBKECGONO68-2025-06-30.zip#59646887 Filing: 213800533NBKECGONO68-2025-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.
2025 2024-07-01 – 2025-06-30	Unavailable Not reported for this period.	DKK 207.45 million Exact value Exact value: 207449000 DKK 2024-07-01 – 2025-06-30: 207449000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2025-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 207449000 DKK Concept: fundies:OperatingCashFlow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 207449000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21282084 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 29.87 million Exact value Exact value: 29867000 DKK 2024-07-01 – 2025-06-30: 29867000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2025-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 29867000 DKK Concept: fundies:CapitalExpenditure Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 29867000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21285962 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 177.58 million Calculation and evidence 207449000 − 29867000 DKK Exact free cash flow: 177582000 DKK 2024-07-01 – 2025-06-30: 207449000 DKK · Inspect Operating Cash Flow · Source 2024-07-01 – 2025-06-30: 29867000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2025-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 177582000 DKK Concept: free-cash-flow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 207449000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21282084 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 29867000 DKK (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21285962 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.
2026 2025-07-01 – 2026-06-30	Unavailable Not reported for this period.	DKK 210.36 million Exact value Exact value: 210356000 DKK 2025-07-01 – 2026-06-30: 210356000 DKK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Operating Cash Flow: 210356000 DKK Concept: fundies:OperatingCashFlow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3AOperatingCashFlow&period=2026-06-30&surface=latest&period_type=duration&start=2025-07-01&unit=DKK&dimensions= Input fundies:OperatingCashFlow: 210356000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21280958 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 28.31 million Exact value Exact value: 28311000 DKK 2025-07-01 – 2026-06-30: 28311000 DKK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Capital Expenditure: 28311000 DKK Concept: fundies:CapitalExpenditure Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68/explain?concept=fundies%3ACapitalExpenditure&period=2026-06-30&surface=latest&period_type=duration&start=2025-07-01&unit=DKK&dimensions= Input fundies:CapitalExpenditure: 28311000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21284777 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.	DKK 182.05 million Calculation and evidence 210356000 − 28311000 DKK Exact free cash flow: 182045000 DKK 2025-07-01 – 2026-06-30: 210356000 DKK · Inspect Operating Cash Flow · Source 2025-07-01 – 2026-06-30: 28311000 DKK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ChemoMetec A/S e · 2026-06-30 ChemoMetec A/S e (esef:213800533NBKECGONO68) Free cash flow: 182045000 DKK Concept: free-cash-flow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/esef/213800533NBKECGONO68?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 210356000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21280958 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 Input fundies:CapitalExpenditure: 28311000 DKK (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://filings.xbrl.org/213800533NBKECGONO68/2026-06-30/ESEF/DK/0/213800533NBKECGONO68-2026-06-30.zip#21284777 Filing: 213800533NBKECGONO68-2026-06-30-ESEF-DK-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

9 filings · 647 latest values · 647 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 213800533NBKECGONO68, esef:213800533NBKECGONO68

Also known as ChemoMetec A/S

ChemoMetec A/S e

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-07-01 – 2026-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation